Averin Capital Acquisition Corp. (ACAA) stock: price, suppliers, customers and institutional ownership
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Averin Capital Acquisition Corp.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Blank Checks
High 9.99 at 12:00 pm ET, low 9.99 at 12:00 pm ET.
We are a special purpose acquisition company incorporated as a Cayman Islands exempted company and incorporated for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not selected any business combination target, and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. We may pursue an initial business combination target in any business or industry. While we may pursue an acquisition opportunity in any business industry or sector, we intend to capitalize on the ability of our management team to identify, acquire and manage a business at the intersection of technology and health that can benefit from our operational expertise. Members of our management team and Averin Capital personnel have significant experience founding, building and scaling businesses in the health and technology ecosystems. Our sponsor is an affiliate of Averin Capital. Averin Capital is a company creation and multi-stage investment firm focused on transformative technologies at the intersection of health and technology. Averin Capital invests across key verticals including artificial intelligence, longevity, data-driven care, and deep technology, with a mission to accelerate innovations that improve human health and extend long-term well-being. Averin applies a collaborative approach, combining scientific rigor, operational expertise, and strategic insight to help visionary teams scale and create lasting impact. As operators, founders, innovators, and investors, Averin seeks to work closely with management teams with the goal of driving growth. Averin operates in key geographies such as Boston, San Francisco, and New York, with a team comprising MDs, PhDs, seasoned entrepreneurs, and health and technology executives. Our executive offices are located in New York, NY.
No case yet. It builds on the next filing, report or 13F period.
Averin Capital Acquisition Corp. has no measured co-movers clearing our correlation floor, so only its SEC classification is shown.
SIC 6770, Blank Checks, from each company's own filings. Largest first.
40 managers report a position worth $193.5M between them, and 16 of them hold 80% of it.
each tick is a filing
ACAA (Averin Capital Acquisition Corp.) has 0 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Select a tie for its filing sentence; select again to open the company. Nearer the centre, the more the filings disclose. Extended: satellites hang off single companies, not bundled sectors.